Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant non-small cell lung cancer and brain metastasis: a retrospective study

BACKGROUND: The aims of the study were to evaluate potential differences among first-line treatment for EGFR mutant (m+) non-small cell lung cancer (NSCLC) patients with brain metastasis in China and to identify the factors influencing survival outcomes. METHODS: In this retrospective study, 172 EGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huijuan, Xing, Ruyue, Li, Mengmeng, Zhang, Mina, Wei, Chunhua, Zhang, Guowei, Niu, Yuanyuan, Ma, Zhiyong, Yan, Xiangtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061743/
https://www.ncbi.nlm.nih.gov/pubmed/36997925
http://dx.doi.org/10.1186/s12885-023-10744-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061743/
https://www.ncbi.nlm.nih.gov/pubmed/36997925
http://dx.doi.org/10.1186/s12885-023-10744-2

Ejemplares similares